About Safeguard ScientificsFounded in 1953 and based in Wayne, Pa., Safeguard Scientifics, Inc. (NYSE: SFE) provides growth capital and operational support to entrepreneurial and innovative healthcare and technology companies in medtech, healthtech, specialty pharmaceuticals, financial technology, digital media, and Enterprise 3.0. For more information, please visit our website at www.safeguard.com.About Sotera WirelessSotera Wireless, Inc. is a San Diego, California based medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera's mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient's freedom of movement. More information on the company can be obtained at www.soterawireless.com or by sending an email to email@example.com. ViSi Mobile® is a registered trademark of Sotera Wireless, Inc. Safeguard Press ResourcesBlog: blog.safeguard.comTwitter: @SafeguardStockTwits: SFELinkedIn: Safeguard ScientificsYouTube: SafeguardSFESlideShare: SafeguardScientifics Forward-looking StatementsExcept for the historical information and discussions contained herein, statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The Company’s forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially, include, among others, managing rapidly changing technologies, limited access to capital, competition, the ability to attract and retain qualified employees, the ability to execute our strategy, the uncertainty of the future performance of our partner companies, acquisitions and dispositions of partner companies, the inability to manage growth, compliance with government regulations and legal liabilities, additional financing requirements, the effect of economic conditions in the business sectors in which our partner companies operate, and other uncertainties described in the Company's filings with the Securities and Exchange Commission. Many of these factors are beyond our ability to predict or control. In addition, as a result of these and other factors, our past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this news release.
Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that provides growth capital and operational support to healthcare and technology companies, deployed $1.33 million as part of a $14.8 million financing for Sotera Wireless, Inc., a San Diego, Calif.-based medical device company that has developed a new wireless patient monitoring platform called ViSi Mobile ®. Sotera will use the proceeds from this financing to build out its sales network and channel distribution partners. In addition to Safeguard, participants in this round included new investor Delphi Ventures and existing investors Sanderling Ventures, Qualcomm Incorporated acting through its venture investment group Qualcomm Ventures, EDBI, Intel Capital, Cerner Capital and West Health Investment Fund. Sotera’s ViSi Mobile platform is a comprehensive vital signs monitoring system that is designed to keep clinicians connected to their patients, whether in or out of bed, or while in transport—“monitoring in motion.” Featuring comfortable body-worn sensors that allow for freedom of movement, the system enables highly accurate, continuous monitoring of all vital signs. The ViSi Mobile system offers an effective, economical solution to enable hospitals to monitor their entire patient population in real time. By some estimates, around 60 percent of the approximately 1,000,000 U.S. hospital beds are not continuously monitored. As a result, an avoidable death occurs every five minutes at U.S. hospitals due solely to inadequate patient monitoring. Global demand could significantly increase that opportunity. “Sotera is led by an experienced management team of healthcare and business professionals who have a track record of building successful businesses,” said James A. Datin, Executive Vice President and Managing Director at Safeguard, who joined Sotera’s board of directors. “We believe that Sotera’s ViSi Mobile addresses a large market, with the opportunity to revolutionize the way hospitals monitor patient vital signs. ViSi Mobile fills an unmet medical need, has the potential to reduce healthcare spending, and can rapidly improve patient management while achieving significant growth. Through this financing, we can provide Sotera with the necessary resources to help increase ViSi Mobile’s penetration into hospitals throughout the United States, and encourage the development of other, complementary products that build upon Sotera’s proprietary technology.” “With $14.8 million in additional capital, we believe that we can accelerate our commercialization and clinical development, and expand the availability of ViSi Mobile to the more than 5,000 hospitals in the United States,” said Tom Watlington, CEO of Sotera. “In addition, we are excited that Safeguard has joined our board of directors. Safeguard is a highly-respected organization with an impressive track record backing successful medical device commercialization and marketing efforts, and we look forward to the value they can bring to us through their domain expertise and partnership.” Safeguard has a 7.7 percent primary ownership stake in Sotera, with the potential to raise that ownership stake to 20 percent in certain scenarios.